Two stocks in Healthcare
Eli Lilly and Company vs Regeneron Pharmaceuticals: profit, growth, debt and price compared
Eli Lilly and Company and Regeneron Pharmaceuticals are each stronger on 3 of 7 figures: Eli Lilly and Company on profit margin, sales growth and dividend; Regeneron Pharmaceuticals on debt, price for its expected profit and price trend.
Save both stocks to your watchlist and revisit their latest fundamentals.
| Eli Lilly and CompanyLLY | Regeneron PharmaceuticalsREGN | |
|---|---|---|
| Net margin | Stronger: 31.9% | 28.5% |
| Revenue growth, past year | Stronger: +38.61% | +36.27% |
| Debt to equity | 122.9% | Stronger: 8.1% |
| Forward P/E | 27.2× | Stronger: 13.3× |
| Dividend yield | Stronger: 0.49% | 0.39% |
| Analysts | Buy · 29 | Buy · 27 |
| From its 200-day average | +21.2% | Stronger: +24.2% |
Share price over the past year
- Eli Lilly and Company+34.2%
- Regeneron Pharmaceuticals+30.4%
18 Nov 202518 Nov 2026
Eli Lilly and Company or Regeneron Pharmaceuticals: which is stronger?
- LLY
Which is more profitable?
Eli Lilly and Company keeps more of each sale as profit: 31.9% against 28.5%.
- LLY
Which is growing its sales faster?
Eli Lilly and Company is growing its sales faster: +38.61% over the past year, against +36.27%.
- REGN
Which has borrowed less?
Regeneron Pharmaceuticals has borrowed less: its debt is 8.1% of what its shareholders own, against 122.9% for Eli Lilly and Company.
- REGN
Which costs less for the profit it is expected to make?
Regeneron Pharmaceuticals costs less for the profit it is expected to make: 13.3× its forward earnings, against 27.2×.
- LLY
Which pays more in dividends?
Eli Lilly and Company pays more back in dividends for what a share costs: 0.49% a year, against 0.39%.
Which do analysts rate higher?
Analysts rate both the same: Buy.
- REGN
Which is in the stronger price trend?
Regeneron Pharmaceuticals' price is in the stronger trend: 24.2% above its 200-day average, against 21.2% above.
What each company does
LLYEli Lilly and Company
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
Reports results on 3 February 2027
REGNRegeneron Pharmaceuticals
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.
Reports results on 28 January 2027
This comparison is just the starting point.
Discover opportunities, understand companies and compare investments in one place. See how StratDeck works
Keep researching
Where next
More comparisons
Free email
Up to speed in minutes, four times a week
Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.
Early access
Become a StratDeck founding user
Use StratDeck, tell us what's missing, and help decide what we build next.
100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.